1-7 of 7
clinical laboratory improvement amendments
Close
Sort by
Journal Articles

Diagnosing HIT: the need for speed

Adam Cuker, Douglas B. Cines
Journal: Blood
Blood (2020) 135 (14): 1082–1083.
https://doi.org/10.1182/blood.2019004676
Published: 2020
Journal Articles

Trial in Progress: Feasibility and Validation Study of the LSC17 Score in Acute Myeloid Leukemia Patients

Tracy Murphy, MDFRCP,FRCPath, Stanley W.K. Ng, PhD, Tong Zhang, Ian King, PhD, Andrea Arruda, Jaime O. Claudio, PhD, Narmin Ibrahimova, Fiona Ferrera, Chantal Rockwell, Zhibin Lu, Natalie Stickle, Carl Virtanen, MSc, Brian Leber, MD, Mitchell Sabloff, MD, Mark D. Minden, MD PhD, Tracy L. Stockley, PhD FCCMG, FACMG, Steven M Chan, MD PhD, Jean C.Y. Wang, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2682.
https://doi.org/10.1182/blood-2019-130532
Published: 2019
Journal Articles

Incidence of Germline ATM Variants in a Consecutive Clinical Cohort of CLL Patients

Benjamin L. Lampson, MD PhD, Svitlana Tyekucheva, PhD, Conner J. Shaughnessy, Annette S. Kim, MD PhD, Jennifer R. Brown, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1731.
https://doi.org/10.1182/blood-2019-127180
Published: 2019
Journal Articles

Dual Driver Mutant BCR-ABL1-Negative Myeloid Neoplasms: Multicenter Clinicopathologic and Genomic Analysis

Zachary D. Epstein-Peterson, MD, Joseph Tripodi, Maria E Arcila, MD, Filiz Sen, MD, Vesna Najfeld, PhD, John Mascarenhas, MD, Ronald Hoffman, MD, Rajit K. Rampal, MD, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4173.
https://doi.org/10.1182/blood-2019-125379
Published: 2019
Journal Articles

Improving Risk Assessment of AML with a Precision Genomic Strategy to Assess Mutation Clearance

Meagan Jacoby, MD, David H Spencer, MD PhD, Emma Hughes, Robert S Fulton, Michelle O'Laughlin, Catrina Fronick, BS, Michael R. Loken, PhD, Jack D Baty, Mark A. Schroeder, MD, Armin Ghobadi, MD, Geoffrey L. Uy, MD, Ravi Vij, MBBS, Brad S Kahl, MD, Amanda F Cashen, MD, Matthew J. Walter, MD, Lukas D Wartman, MD, John S. Welch, MD PhD, John F. DiPersio, MD PhD, Peter Westervelt, MD PhD, Timothy J Ley, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5277.
https://doi.org/10.1182/blood-2018-99-114979
Published: 2018
Journal Articles

Comprehensive Genomic Profiling (CGP) Identifies Novel BCL6 Rearrangements in Diverse Subtypes of Non-Hodgkin Lymphoma (NHL) As Well As Known Rearrangements Not Detected Using Standard of Care (SOC) Assays

Jo-Anne Vergilio, MD, Laurie M Gay, PhD, Lei Zhong, PhD, Mark Rosenzweig, PhD, Yakov Chudnovsky, PhD, Jie He, PhD, Michelle Nahas, PhD, Siraj M Ali, MD PhD, Sugganth Daniel, MD, Shakti Ramkissoon, MD PhD, James Suh, MD, Julia A Elvin, MD PhD, Tariq I Mughal, MD FRCP, Philip J Stephens, PhD, Vincent A Miller, MD, Rachel Erlich, PhD, Jeffrey S Ross, MD, Eric A Severson, MD PhD MMSc, Samantha Morley, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 417.
https://doi.org/10.1182/blood.V130.Suppl_1.417.417
Published: 2017
Journal Articles

Cladribine Combined with Idarubicin and Ara-C (CLIA) As a Frontline and Salvage Treatment for Young Patients (≤65 yrs) with Acute Myeloid Leukemia

Preetesh Jain, MBBS,MDDM,PhD, Hagop M. Kantarjian, MD, Farhad Ravandi, MBBS, Elias Jabbour, MD, Naval Daver, MD, Naveen Pemmaraju, MD, Courtney D DiNardo, MD, Yesid Alvarado, MD, Nitin Jain, MD, Gautam Borthakur, MBBS, Srdan Verstovsek, MD PhD, Alessandra Ferrajoli, MD, Maro Ohanian, DO, Marina Konopleva, MD PhD, Kiran Naqvi, MD, Tina Fitch, RN, Guillermo Garcia-Manero, MD, Jorge E. Cortes, MD, Zeev Estrov, MD, Tapan M. Kadia, MD
Journal: Blood
Blood (2016) 128 (22): 1639.
https://doi.org/10.1182/blood.V128.22.1639.1639
Published: 2016